Joel Greenblatt | Gotham Asset Management, Llc

Fund Stats for Q4 2013Joel Greenblatt is the managing partner of Gotham Asset Management, Llc. The 13F filing for 2013 Q4 included $4.20B in managed 13F securities and a top 10 holdings concentration of 6.29%. Gotham Asset Management, Llc's largest holding is SPDR S&P 500 ETF Trust with shares held of 179.61K. 10kreader has 37 13F filings available for Gotham Asset Management, Llc.Joel Greenblatt is the managing partner of Gotham Asset Management, Llc. The 13F filing for 2013 Q4 included $4.20B in managed 13F securities and a top 10 holdings concentration of 6.29%. Gotham Asset...

About Joel GreenblattKnown for the invention of Magic Formula Investing, and founder of the New York Securities Auction Corporation (NYSAC), Greenblatt is founder and managing partner of Gotham Asset Management, LLC. He is the author of two investment books, including 'The Little Book that Beats the Market.' He is also an Adjunct Professor with Columbia Business School.Greenblatt tries to find cheap and good companies. He looks for value with a catalyst, so nice things happen sooner. Greenblatt likes special situations, and thinks that they are simply different places to find cheap stocks. In his own hedge fund, Greenblatt uses the basic principals in the Magic Formula: Look for high ROC and high earnings yield. He tries to figure out what 'normalized earnings' will be 3-4 years into the future. Greenblatt makes sure the stock is very cheap based on normalized earnings.source: gurufocus.comKnown for the invention of Magic Formula Investing, and founder of the New York Securities Auction Corporation (NYSAC), Greenblatt is founder and managing partner of Gotham Asset Management, LLC. He i...

Go to:

Company	Ticker	Market Value	% Portfolio	Shares	Change	Chg. Shares	Quarter End Price	Current Price	Yearly High	Yearly Low	Market Cap	% Owned
SPDR S&P 500 ETF Trust	SPY	33.17M	0.79%	179.61K	1.29%	2.29K	$184.69	$390.12	$479.98	$362.17	358.05B	0.02%
Pdl Biopharma Inc		28.22M	0.67%	3.34M	15.69%	453.41K	$8.44
Myriad Genetics, Inc.	MYGN	27.62M	0.66%	1.32M	36.27%	350.33K	$20.98	$21.52	$35.31	$16.02	1.74B	1.63%
Altria Group, Inc.	MO	27.43M	0.65%	714.63K	8.86%	58.18K	$38.39	$42.01	$57.05	$41	75.65B	0.04%
Endo Health Solutions Inc		26.78M	0.64%	397.02K	-23.94%	-124.97K	$67.46
Willis Towers Watson Public Limited Company	WTW	26.28M	0.63%	798.03K	54.45%	281.33K	$32.93	$206.75	$249.7	$187.89	22.74B	0.73%
Cisco Systems, Inc.	CSCO	26.27M	0.63%	1.17M	27.11%	249.76K	$22.43	$43.29	$64.29	$40.82	177.87B	0.03%
Coach Inc		23.24M	0.55%	414.06K	3.37%	13.49K	$56.13
Reynolds American Inc		23.11M	0.55%	462.39K	90.72%	219.95K	$49.99
Oracle Corporation	ORCL	22.32M	0.53%	583.51K	14.58%	74.26K	$38.26	$70.24	$106.34	$63.76	189.34B	0.02%
United Therapeutics Corporation	UTHR	22.00M	0.52%	194.59K	-47.71%	-177.55K	$113.08	$220.64	$245.48	$158.38	10.04B	0.43%
Valueclick Inc		21.83M	0.52%	934.04K	11.66%	97.51K	$23.37
Pilgrim's Pride Corporation	PPC	21.75M	0.52%	1.34M	75.70%	576.82K	$16.25	$25.65	$34.66	$20.23	6.24B	0.55%
Lorillard Inc		21.71M	0.52%	428.44K	9.29%	36.41K	$50.68
GameStop Corp.	GME	21.48M	0.51%	435.94K	253.91%	312.76K	$49.26	$28.61	$63.9225	$19.395	8.71B	0.14%
Spirit AeroSystems Holdings, Inc.	SPR	21.33M	0.51%	625.97K	New	625.97K	$34.08	$26.53	$53.31	$26.18	2.79B	0.60%
The Buckle, Inc.	BKE	21.29M	0.51%	405.14K	102.10%	204.68K	$52.56	$33.24	$57.1	$26.5	1.67B	0.81%
International Game Technolog		21.15M	0.50%	1.16M	121.31%	638.46K	$18.16
The Goodyear Tire & Rubber Company	GT	21.08M	0.50%	883.76K	36.07%	234.25K	$23.85	$13.08	$24.89	$10.33	3.70B	0.31%
Chemed Corporation	CHE	21.01M	0.50%	274.22K	12.61%	30.70K	$76.62	$481.44	$539.87	$403	7.18B	1.84%

Holdings Breakdown

Disclaimer: Investor holdings are derived from 13F filings which are required to be filed by all institutional investment managers with at least $100 million in assets under management. Limitations to this data include but are not limited to: (1) SEC does not review 13Fs for accuracy or completeness, (2) cash, foreign stocks, short positions, and a variety of other assets are not required to be reported, (3) 13Fs are often filed 45 days after the end of the quarter, by which time a manager's positions and outlook could have changed significantly, (4) the market value does not tell us at what price the manager acquired the asset, and (5) data is only available starting mid 2013. Please do your own research before drawing any conclusions from this data.